INSURANCE AUSTRALIA GROUP LIMITED (IAG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IAG

IAG - INSURANCE AUSTRALIA GROUP LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Insurance Australia Group is an insurance company formed by the demutualisation of the NRMA Insurance business in July 2000. It is not a customer-facing brand, but an umbrella organisation that holds many well known insurance brands in Australia, NZ and Asia, incl NRMA Insurance and CGU.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.88

23 Sep
2026

-0.190

OPEN

$7.89

-2.35%

HIGH

$7.99

4,162,080

LOW

$7.81

TARGET
$7.938 0.7% upside
Franking for last dividend paid out: 80%
OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . MPL . NHF . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
IAG: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 43.4 45.5 xxx
DPS (cps) xxx 32.0 33.0 xxx
EPS Growth xxx - 24.5% 4.7% xxx
DPS Growth xxx 3.2% 3.1% xxx
PE Ratio xxx N/A 17.1 xxx
Dividend Yield xxx N/A 4.2% xxx
Div Pay Ratio(%) xxx 73.7% 72.6% xxx

Dividend yield today if purchased 3 years ago: 5.55%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.11

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/08 - ex-div 20.00c (franking 80%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx43.4
DPS All xxxxxxxxxxxxxxx32.0
Sales/Revenue xxxxxxxxxxxxxxx19,365.0 M
Book Value Per Share xxxxxxxxxxxxxxx310.5
Net Operating Cash Flow xxxxxxxxxxxxxxx1,042.0 M
Net Profit Margin xxxxxxxxxxxxxxx5.28 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx14.04 %
Return on Invested Capital xxxxxxxxxxxxxxx9.92 %
Return on Assets xxxxxxxxxxxxxxx3.79 %
Return on Equity xxxxxxxxxxxxxxx14.04 %
Return on Total Capital xxxxxxxxxxxxxxx17.67 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx85 M
Long Term Debt xxxxxxxxxxxxxxx3,158 M
Total Debt xxxxxxxxxxxxxxx3,243 M
Goodwill - Gross xxxxxxxxxxxxxxx2,880 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx2,047 M
Price To Book Value xxxxxxxxxxxxxxx2.61

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxxxxxxxx0.00 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,710 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx12,470 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

16/09/2026

1

Buy

$8.80

11.68%

Citi considers entry price increasingly important across Australian and New Zealand insurers, given solid but modest growth prospects and broadly fair valuations.

General insurers are expected to deliver relatively stable underlying margins, modest revenue growth and strong capital generation. It is felt Insurance Australia Group and Suncorp Group offer downside protection and potential reported-margin upside.

Elsewhere, Citi believes QBE Insurance may offer stronger organic growth.

Among private health insurers, Medibank Private's near-term outlook appears more certain than nib Holdings, although its valuation is higher and growth remains subdued, the analysts explain.

Insurance Australia Group and AUB Group are Citi's preferred sector exposures, with Buy ratings.

For Insurance Australia Group: Buy; $8.80 target.

FORECAST
Citi forecasts a full year FY27 EPS of 48.00 cents.
Citi forecasts a full year FY28 EPS of 52.00 cents.

Ord Minnett

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

17/08/2026

3

Neutral

$7.85

-0.38%

Jarden retains a Neutral rating for Insurance Australia Group with its target price decreased to $7.85 from $8.00 following a slightly soft headline result featuring divergent trends across product lines and geographies.

During the second half of FY26, RIA ex-RACQ delivered top-line re-acceleration alongside margin expansion, whereas competitive intensity drove sharp declines across New Zealand top-line performance and margin erosion.

The analyst views FY27 gross written premium guidance of 5%-8% as optimistic, noting reliance on foreign exchange benefits or material improvements within New Zealand intermediated channels.

The broker's estimates consider the mid-point of margin guidance reasonable, largely underpinned by cost reductions and a stronger interest rate outlook.

The analyst suggests the final RACWA decision presents a positive catalyst by either supporting further expansion across personal lines or potentially underpinning a share buyback exceeding $1bn.
Access Extra Coverage Research History >

IAG STOCK CHART

FNArena News on IAG

1
Next Week At A Glance – 14-18 Sep 2026

Sep 11 2026 - Weekly Reports
2
ASIC Watch: AI Governance As Board Priority

Sep 07 2026 - Australia
3
Weekly Ratings, Targets, Forecast Changes – 21-08-26

Aug 24 2026 - Weekly Reports
4
Australian Broker Call *Extra* Edition – Aug 17, 2026

Aug 17 2026 - Daily Market Reports
5
FNArena Corporate Results Monitor – 14-08-2026

Aug 14 2026 - Australia

Latest Insurance News

1
The Rebuilding Of Tower

Apr 15 2026 - Small Caps
2
Treasure Chest: AI Risks To Insurance Brokers

Feb 11 2026 - Treasure Chest
3
ASIC Watch: Ai Governance Tax Hits Insurers

Dec 22 2025 - Australia
4
Insurance Sector’s AI Challenges Have Arrived

Nov 03 2025 - Australia
5
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
6
IAG Shares Breaking Out

Jan 21 2025 - Technicals
7
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
8
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
9
Steadfast’s Long March

Jul 02 2024 - Australia
10
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals